Curis
CRIS
#10285
Rank
ยฃ16.73 M
Marketcap
ยฃ0.42
Share price
-1.83%
Change (1 day)
-77.18%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -ยฃ24.78 Million

According to Curis's latest financial reports the company's current earnings are ยฃ11.65 Million. In 2024 the company made an earning of -ยฃ31.4 Million, an increase over its 2023 earnings that were of -ยฃ33.32 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ24.78 Million-21.08%
2024 -ยฃ31.4 Million-5.77%
2023 -ยฃ33.32 Million-13.1%
2022 -ยฃ38.35 Million27.52%
2021 -ยฃ30.07 Million65.09%
2020 -ยฃ18.22 Million-9.1%
2019 -ยฃ20.04 Million-4.73%
2018 -ยฃ21.03 Million-41.95%
2017 -ยฃ36.23 Million-14.37%
2016 -ยฃ42.31 Million3.55%
2015 -ยฃ40.86 Million271.52%
2014 -ยฃ11 Million76.64%
2013 -ยฃ6.23 Million
2011 -ยฃ5.29 Million27.76%
2010 -ยฃ4.14 Million-43.87%
2009 -ยฃ7.38 Million-23.44%
2008 -ยฃ9.63 Million56.66%
2007 -ยฃ6.15 Million-16.71%
2006 -ยฃ7.39 Million-36.92%
2005 -ยฃ11.7 Million156.25%
2004 -ยฃ4.57 Million-37.24%
2003 -ยฃ7.28 Million-93.34%
2002 -ยฃ0.11 Billion86.79%
2001 -ยฃ58.48 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ7.48 B-31,404.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ6.84 B-28,750.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-ยฃ45.43 Million 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
ยฃ0.69 B-2,990.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ0.22 Billion 782.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-ยฃ18.18 Million-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.12 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA